EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016.

REUTERS/Jim Bourg/File Photo

Go to Source

Mylan pays $465 mln to settle EpiPen Medicaid rebate dispute
Robert Green Medicaid News